Home Uncategorized Gilead Shares Gain After Launching Phase 3 Studies For Coronavirus Treatment

Gilead Shares Gain After Launching Phase 3 Studies For Coronavirus Treatment

Gilead Sciences (GILD) – Get Report shares extended gains in pre-market trading Thursday after the drugmaker said its nascent coronavirus treatment will undergo advance human testing in Asia.
Gilead said that around 1,000 patients in the region, suffering fr…
Read More

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Most Popular

DHS Secretary Sets the Record Straight on Fake News on Portland Riots

Chad Wolf, acting secretary of the Department of Homeland Security, hit back at a press conference in DHS headquarters in Washington, D.C. on Tuesday against media reports that the Trump administrati…

Trump Raises $20 Million in First-Ever Virtual Fundraiser

President Donald Trump raised an eye-popping $20 million on Tuesday night in his first-ever virtual fundraiser, from a total of more than 300,000 individual donors who participated. This is a great …

ACLU: Constitution Requires Illegal Aliens Count Toward Congressional Apportionment

The American Civil Liberties Union (ACLU), as well as other migration lobbying organizations, claims it is “unconstitutional” not to count illegal aliens when apportioning congressional representatio…

US House poised to vote on reversing Trump’s Muslim ban

The United States House of Representatives is set to vote on Wednesday on legislation reversing President Donald Trump's controversial ban on immigration from Muslim countries. The bill, called the …

Recent Comments

Business and Economic News :: Debtly